Nomura Holdings Inc Novavax Inc Transaction History

Nomura Holdings Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.89 - $20.97 $79,815 - $430,262	20,518 New	20,518 $259,000
Q3 2023 Nov 14, 2023	BUY	$6.81 - $9.74 $69,237 - $99,026	10,167 New	10,167 $73,000
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $358,047 - $743,037	-9,869 Reduced 38.72%	15,618 $886,000
Q1 2022 May 18, 2022	SELL	$69.73 - $142.9 $607,696 - $1.25 Million	-8,715 Reduced 25.48%	25,487 $1.9 Million
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $1.73 Million - $2.81 Million	12,878 Added 60.39%	34,202 $4.95 Million
Q3 2021 Nov 15, 2021	BUY	$177.8 - $270.58 $2.62 Million - $3.99 Million	14,730 Added 223.38%	21,324 $3.85 Million
Q2 2021 Aug 16, 2021	BUY	$121.0 - $257.67 $797,874 - $1.7 Million	6,594 New	6,594 $1.4 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $520,611 - $1.47 Million	-4,608 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $362,833 - $642,816	4,608 New	4,608 $514,000

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $680M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.